INTERACTIONS BETWEEN DRUG-RESISTANCE MUTATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE

被引:136
作者
LARDER, BA
机构
[1] Antiviral Therapeutic Research Unit, Wellcome Research Laboratories, Beckenham, Kent BR3 3BS, South Eden Park Road
关键词
D O I
10.1099/0022-1317-75-5-951
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
[No abstract available]
引用
收藏
页码:951 / 957
页数:7
相关论文
共 43 条
  • [1] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) STRAINS SELECTED FOR RESISTANCE AGAINST THE HIV-1-SPECIFIC [2',5'-BIS-O-(TERT-BUTYLDIMETHYLSILYL)-3'-SPIRO-5''-(4''-AMINO-1'',2''-OXATHIOLE-2'',2''-DIOXIDE)]-BETA-D-PENTOFURANOSYL (TSAO) NUCLEOSIDE ANALOGS RETAIN SENSITIVITY TO HIV-1-SPECIFIC NONNUCLEOSIDE INHIBITORS
    BALZARINI, J
    KARLSSON, A
    VANDAMME, AM
    PEREZPEREZ, MJ
    ZHANG, H
    VRANG, L
    OBERG, B
    BACKBRO, K
    UNGE, T
    SANFELIX, A
    VELAZQUEZ, S
    CAMARASA, MJ
    DECLERCQ, E
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (15) : 6952 - 6956
  • [2] ZIDOVUDINE SENSITIVITY OF HUMAN IMMUNODEFICIENCY VIRUSES FROM HIGH-RISK, SYMPTOM-FREE INDIVIDUALS DURING THERAPY
    BOUCHER, CAB
    TERSMETTE, M
    LANGE, JMA
    KELLAM, P
    DEGOEDE, REY
    MULDER, JW
    DARBY, G
    GOUDSMIT, J
    LARDER, BA
    [J]. LANCET, 1990, 336 (8715) : 585 - 590
  • [3] ORDERED APPEARANCE OF ZIDOVUDINE RESISTANCE MUTATIONS DURING TREATMENT OF 18 HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE SUBJECTS
    BOUCHER, CAB
    OSULLIVAN, E
    MULDER, JW
    RAMAUTARSING, C
    KELLAM, P
    DARBY, G
    LANGE, JMA
    GOUDSMIT, J
    LARDER, BA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (01) : 105 - 110
  • [4] HIGH-LEVEL RESISTANCE TO (-) ENANTIOMERIC 2'-DEOXY-3'-THIACYTIDINE IN-VITRO IS DUE TO ONE AMINO-ACID SUBSTITUTION IN THE CATALYTIC SITE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
    BOUCHER, CAB
    CAMMACK, N
    SCHIPPER, P
    SCHUURMAN, R
    ROUSE, P
    WAINBERG, MA
    CAMERON, JM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (10) : 2231 - 2234
  • [5] COMPREHENSIVE MUTANT ENZYME AND VIRAL VARIANT ASSESSMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE RESISTANCE TO NONNUCLEOSIDE INHIBITORS
    BYRNES, VW
    SARDANA, VV
    SCHLEIF, WA
    CONDRA, JH
    WATERBURY, JA
    WOLFGANG, JA
    LONG, WJ
    SCHNEIDER, CL
    SCHLABACH, AJ
    WOLANSKI, BS
    GRAHAM, DJ
    GOTLIB, L
    RHODES, A
    TITUS, DL
    ROTH, E
    BLAHY, OM
    QUINTERO, JC
    STASZEWSKI, S
    EMINI, EA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (08) : 1576 - 1579
  • [6] BYRNES VW, IN PRESS ANTIMICROBI
  • [7] USE OF EVOLUTIONARY LIMITATIONS OF HIV-1 MULTIDRUG RESISTANCE TO OPTIMIZE THERAPY
    CHOW, YK
    HIRSCH, MS
    MERRILL, DP
    BECHTEL, LJ
    ERON, JJ
    KAPLAN, JC
    DAQUILA, RT
    [J]. NATURE, 1993, 361 (6413) : 650 - 654
  • [8] HIV-1 ERROR REVEALED
    CHOW, YK
    HIRSCH, MS
    KAPLAN, JC
    DAQUILA, RT
    [J]. NATURE, 1993, 364 (6439) : 679 - 679
  • [9] CUEWEKE TJ, 1993, P NATIONAL ACADEMY S, V90, P4713
  • [10] HIV AND MULTIDRUG-RESISTANCE
    EMINI, EA
    GRAHAM, DJ
    GOTLIB, L
    CONDRA, JH
    BYRNES, VW
    SCHLEIF, WA
    [J]. NATURE, 1993, 364 (6439) : 679 - 679